United States Healthcare Providers & Services

Quest Diagnostics Inc (DGX)

Quest Diagnostics insiders executed nine sales totaling approximately 22 million dollars over the past quarter. These divestments occurred as the stock price reached near-record highs. Following a positive earnings report in late October, leadership and directors continued systematic liquidation of equity holdings, reflecting a consistent pattern of planned disposals rather than opportunistic market timing.
Ticker: DGX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Quest Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
331.78
Quantity 85,641 +46.6%
Value US$1,830,262
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
476.67
Quantity 35,769 -8.0%
Value US$638,975
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
19.78
Quantity 89,145 +17.7%
Value US$800,116
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
248.38
Quantity 1,000 -2.8%
Value US$100,000
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
246.98
Quantity 1,000 -1.4%
Value US$100,000
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
246.26
Quantity 1,000 -6.6%
Value US$100,000
1.5
Doherty Catherine T. Executive Vice President Officer
Transaction date
Planned sale
Price
245.45
Quantity 1,000 -4.1%
Value US$100,000
1.5
Doherty Catherine T. Officer Officer
Transaction date
Proposed sale
Price
252.64
Quantity 1,000
Value US$100,000
0.9
PFEIFFER GARY M Non-Executive Director
Transaction date
Planned sale
Price
243.00
Quantity 1,000 -3.9%
Value US$100,000
0.9
PFEIFFER GARY M Director Non-Executive Director
Transaction date
Proposed sale
Price
243.00
Quantity 1,000
Value US$100,000
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
242.72
Quantity 10,000 -7.6%
Value US$2,427,200
Davis J. E. Officer; Director Executive Director
Transaction date
Proposed sale
Price
242.72
Quantity 10,000
Value US$2,427,200
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
244.51
Quantity 430 -1.1%
Value US$105,141
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
243.63
Quantity 6,237 -14.1%
Value US$1,519,505
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
242.88
Quantity 16,010 -26.6%
Value US$3,888,437
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
243.11
Quantity 22,677
Value US$5,513,082
3.3
DELANEY MARK E SVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
235.18
Quantity 1,600 -13.4%
Value US$376,288
3.3
DELANEY MARK E Officer Officer
Transaction date
Proposed sale
Price
235.18
Quantity 1,600
Value US$376,288
2.3
KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer
Transaction date
Planned sale
Price
200.00
Quantity 8,147 -37.6%
Value US$1,629,400
2.3
KUPPUSAMY KARTHIK Officer Officer
Transaction date
Proposed sale
Price
200.00
Quantity 8,147
Value US$1,629,400
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
194.14
Quantity 10,000 -7.0%
Value US$1,941,400
Davis J. E. Officer; Director Executive Director
Transaction date
Proposed sale
Price
194.14
Quantity 10,000
Value US$1,941,360
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
206.21
Quantity 3,878 -9.4%
Value US$799,682
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
206.21
Quantity 2,855 -15.8%
Value US$588,730
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
206.21
Quantity 5,558 -7.6%
Value US$1,146,115
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
206.21
Quantity 3,878
Value US$799,682
1.5
Doherty Catherine T. Officer Officer
Transaction date
Proposed sale
Price
206.21
Quantity 5,558
Value US$1,146,115
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
206.21
Quantity 2,855
Value US$588,730
2.3
KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer
Transaction date
Sale
Price
204.86
Quantity 2,628 -16.4%
Value US$538,372
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
207.73
Quantity 526 -1.4%
Value US$109,266
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
207.73
Quantity 632 -0.9%
Value US$131,285
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
207.73
Quantity 410 -2.6%
Value US$85,169
1.5
Doherty Catherine T. Officer Officer
Transaction date
Proposed sale
Price
207.73
Quantity 632
Value US$131,285
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
207.73
Quantity 526
Value US$109,266
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
207.73
Quantity 410
Value US$85,169
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
212.52
Quantity 10,000 -7.9%
Value US$2,125,200
Davis J. E. Officer; Director Executive Director
Transaction date
Proposed sale
Price
212.52
Quantity 10,000
Value US$2,125,200
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
204.83
Quantity 958 -5.7%
Value US$196,227
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
204.83
Quantity 1,111 -2.8%
Value US$227,566
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
204.83
Quantity 1,433 -2.1%
Value US$293,521
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
204.83
Quantity 958
Value US$196,227
1.5
Doherty Catherine T. Officer Officer
Transaction date
Proposed sale
Price
204.83
Quantity 1,433
Value US$293,521
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
204.83
Quantity 1,111
Value US$227,566
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
209.10
Quantity 351 -0.5%
Value US$73,395
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
208.21
Quantity 1,619 -2.3%
Value US$337,093
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
207.08
Quantity 3,500 -4.8%
Value US$724,788
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
206.37
Quantity 10,122 -12.1%
Value US$2,088,883
1.5
Doherty Catherine T. EVP, Regional Businesses Officer
Transaction date
Planned sale
Price
205.21
Quantity 10,573 -11.2%
Value US$2,169,656
1.5
Doherty Catherine T. Officer Officer
Transaction date
Proposed sale
Price
207.48
Quantity 26,165
Value US$5,428,714
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
204.00
Quantity 5,662 -26.9%
Value US$1,155,048
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
204.00
Quantity 5,662
Value US$1,155,048
2.6
Gregg Vicky B Non-Executive Director
Transaction date
Sale
Price
191.76
Quantity 1,250 -6.8%
Value US$239,700
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
192.97
Quantity 4,747 -3.8%
Value US$916,037
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
192.27
Quantity 41,004 -24.7%
Value US$7,883,901
Davis J. E. CEO and President Executive Director
Transaction date
Planned sale
Price
191.59
Quantity 9,342 -5.3%
Value US$1,789,823
Davis J. E. Officer; Director Executive Director
Transaction date
Proposed sale
Price
192.22
Quantity 55,093
Value US$10,589,762
2.6
Gregg Vicky B Director Non-Executive Director
Transaction date
Proposed sale
Price
191.76
Quantity 1,250
Value US$239,700
3.3
DELANEY MARK E SVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
187.35
Quantity 7,946 -51.3%
Value US$1,488,683
3.3
DELANEY MARK E Officer Officer
Transaction date
Proposed sale
Price
187.35
Quantity 7,946
Value US$1,488,683
0.9
PFEIFFER GARY M Non-Executive Director
Transaction date
Sale
Price
182.40
Quantity 1,482 -4.8%
Value US$270,317
0.9
PFEIFFER GARY M Director Non-Executive Director
Transaction date
Proposed sale
Price
182.40
Quantity 1,482
Value US$270,317
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
188.66
Quantity 144 -0.4%
Value US$27,167
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
187.22
Quantity 83 -0.2%
Value US$15,539
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
188.13
Quantity 227
Value US$42,706
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
187.02
Quantity 175 -0.5%
Value US$32,729
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
187.02
Quantity 175
Value US$32,729
2.7
PREVOZNIK MICHAEL E SVP & General Counsel Officer
Transaction date
Planned sale
Price
187.12
Quantity 28,288 -42.6%
Value US$5,293,313
2.7
PREVOZNIK MICHAEL E Officer Officer
Transaction date
Proposed sale
Price
187.12
Quantity 28,288
Value US$5,293,313
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
185.00
Quantity 1,975 -11.5%
Value US$365,375
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
185.00
Quantity 1,975
Value US$365,375
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
183.00
Quantity 4,532 -20.8%
Value US$829,356
1.5
Plewman Patrick Director Non-Executive Director
Transaction date
Proposed sale
Price
183.00
Quantity 4,532
Value US$829,356
1.5
Plewman Patrick SVP for Diagnostic Services Officer
Transaction date
Planned sale
Price
180.00
Quantity 1,975 -10.3%
Value US$355,500
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
180.00
Quantity 72
Value US$12,960
1.5
Plewman Patrick Officer Officer
Transaction date
Proposed sale
Price
180.00
Quantity 1,903
Value US$342,540
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
85,641 +46.6%
331.78
US$1,830,262 		85,641 +46.6% 331.78 US$1,830,262
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
35,769 -8.0%
476.67
US$638,975 		35,769 -8.0% 476.67 US$638,975
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
89,145 +17.7%
19.78
US$800,116 		89,145 +17.7% 19.78 US$800,116
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
1,000 -2.8%
248.38
US$100,000 		1,000 -2.8% 248.38 US$100,000
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
1,000 -1.4%
246.98
US$100,000 		1,000 -1.4% 246.98 US$100,000
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
1,000 -6.6%
246.26
US$100,000 		1,000 -6.6% 246.26 US$100,000
2026-11-05 2026-11-03 PlS Planned sale
1.5
Doherty Catherine T.

Executive Vice President

Officer
1,000 -4.1%
245.45
US$100,000 		1,000 -4.1% 245.45 US$100,000
2026-11-03 2026-11-03 PrS Proposed sale
1.5
Doherty Catherine T.

Officer

Officer
1,000
252.64
US$100,000 		1,000 252.64 US$100,000
2026-10-28 2026-10-26 PlS Planned sale
0.9
PFEIFFER GARY M
Non-Executive Director
1,000 -3.9%
243.00
US$100,000 		1,000 -3.9% 243.00 US$100,000
2026-10-26 2026-10-26 PrS Proposed sale
0.9
PFEIFFER GARY M

Director

Non-Executive Director
1,000
243.00
US$100,000 		1,000 243.00 US$100,000
2026-09-03 2026-09-01 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
10,000 -7.6%
242.72
US$2,427,200 		10,000 -7.6% 242.72 US$2,427,200
2026-09-01 2026-09-01 PrS Proposed sale
Davis J. E.

Officer; Director

Executive Director
10,000
242.72
US$2,427,200 		10,000 242.72 US$2,427,200
2026-08-31 2026-08-28 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
430 -1.1%
244.51
US$105,141 		430 -1.1% 244.51 US$105,141
2026-08-31 2026-08-28 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
6,237 -14.1%
243.63
US$1,519,505 		6,237 -14.1% 243.63 US$1,519,505
2026-08-31 2026-08-28 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
16,010 -26.6%
242.88
US$3,888,437 		16,010 -26.6% 242.88 US$3,888,437
2026-08-28 2026-08-28 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
22,677
243.11
US$5,513,082 		22,677 243.11 US$5,513,082
2026-07-29 2026-07-28 PlS Planned sale
3.3
DELANEY MARK E

SVP & Chief Commercial Officer

Officer
1,600 -13.4%
235.18
US$376,288 		1,600 -13.4% 235.18 US$376,288
2026-07-28 2026-07-28 PrS Proposed sale
3.3
DELANEY MARK E

Officer

Officer
1,600
235.18
US$376,288 		1,600 235.18 US$376,288
2026-06-08 2026-06-04 PlS Planned sale
2.3
KUPPUSAMY KARTHIK

SVP, Clinical Solutions

Officer
8,147 -37.6%
200.00
US$1,629,400 		8,147 -37.6% 200.00 US$1,629,400
2026-06-04 2026-06-04 PrS Proposed sale
2.3
KUPPUSAMY KARTHIK

Officer

Officer
8,147
200.00
US$1,629,400 		8,147 200.00 US$1,629,400
2026-06-02 2026-06-01 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
10,000 -7.0%
194.14
US$1,941,400 		10,000 -7.0% 194.14 US$1,941,400
2026-06-01 2026-06-01 PrS Proposed sale
Davis J. E.

Officer; Director

Executive Director
10,000
194.14
US$1,941,360 		10,000 194.14 US$1,941,360
2026-03-06 2026-03-05 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
3,878 -9.4%
206.21
US$799,682 		3,878 -9.4% 206.21 US$799,682
2026-03-06 2026-03-05 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
2,855 -15.8%
206.21
US$588,730 		2,855 -15.8% 206.21 US$588,730
2026-03-06 2026-03-05 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
5,558 -7.6%
206.21
US$1,146,115 		5,558 -7.6% 206.21 US$1,146,115
2026-03-05 2026-03-05 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
3,878
206.21
US$799,682 		3,878 206.21 US$799,682
2026-03-05 2026-03-05 PrS Proposed sale
1.5
Doherty Catherine T.

Officer

Officer
5,558
206.21
US$1,146,115 		5,558 206.21 US$1,146,115
2026-03-05 2026-03-05 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
2,855
206.21
US$588,730 		2,855 206.21 US$588,730
2026-03-06 2026-03-04 S Sale
2.3
KUPPUSAMY KARTHIK

SVP, Clinical Solutions

Officer
2,628 -16.4%
204.86
US$538,372 		2,628 -16.4% 204.86 US$538,372
2026-03-04 2026-03-03 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
526 -1.4%
207.73
US$109,266 		526 -1.4% 207.73 US$109,266
2026-03-04 2026-03-03 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
632 -0.9%
207.73
US$131,285 		632 -0.9% 207.73 US$131,285
2026-03-04 2026-03-03 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
410 -2.6%
207.73
US$85,169 		410 -2.6% 207.73 US$85,169
2026-03-03 2026-03-03 PrS Proposed sale
1.5
Doherty Catherine T.

Officer

Officer
632
207.73
US$131,285 		632 207.73 US$131,285
2026-03-03 2026-03-03 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
526
207.73
US$109,266 		526 207.73 US$109,266
2026-03-03 2026-03-03 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
410
207.73
US$85,169 		410 207.73 US$85,169
2026-03-04 2026-03-02 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
10,000 -7.9%
212.52
US$2,125,200 		10,000 -7.9% 212.52 US$2,125,200
2026-03-02 2026-03-02 PrS Proposed sale
Davis J. E.

Officer; Director

Executive Director
10,000
212.52
US$2,125,200 		10,000 212.52 US$2,125,200
2026-02-20 2026-02-19 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
958 -5.7%
204.83
US$196,227 		958 -5.7% 204.83 US$196,227
2026-02-20 2026-02-19 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
1,111 -2.8%
204.83
US$227,566 		1,111 -2.8% 204.83 US$227,566
2026-02-20 2026-02-19 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
1,433 -2.1%
204.83
US$293,521 		1,433 -2.1% 204.83 US$293,521
2026-02-19 2026-02-19 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
958
204.83
US$196,227 		958 204.83 US$196,227
2026-02-19 2026-02-19 PrS Proposed sale
1.5
Doherty Catherine T.

Officer

Officer
1,433
204.83
US$293,521 		1,433 204.83 US$293,521
2026-02-19 2026-02-19 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
1,111
204.83
US$227,566 		1,111 204.83 US$227,566
2026-02-17 2026-02-13 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
351 -0.5%
209.10
US$73,395 		351 -0.5% 209.10 US$73,395
2026-02-17 2026-02-13 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
1,619 -2.3%
208.21
US$337,093 		1,619 -2.3% 208.21 US$337,093
2026-02-17 2026-02-13 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
3,500 -4.8%
207.08
US$724,788 		3,500 -4.8% 207.08 US$724,788
2026-02-17 2026-02-13 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
10,122 -12.1%
206.37
US$2,088,883 		10,122 -12.1% 206.37 US$2,088,883
2026-02-17 2026-02-13 PlS Planned sale
1.5
Doherty Catherine T.

EVP, Regional Businesses

Officer
10,573 -11.2%
205.21
US$2,169,656 		10,573 -11.2% 205.21 US$2,169,656
2026-02-13 2026-02-13 PrS Proposed sale
1.5
Doherty Catherine T.

Officer

Officer
26,165
207.48
US$5,428,714 		26,165 207.48 US$5,428,714
2026-02-12 2026-02-10 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
5,662 -26.9%
204.00
US$1,155,048 		5,662 -26.9% 204.00 US$1,155,048
2026-02-10 2026-02-10 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
5,662
204.00
US$1,155,048 		5,662 204.00 US$1,155,048
2025-11-28 2025-11-25 S Sale
2.6
Gregg Vicky B
Non-Executive Director
1,250 -6.8%
191.76
US$239,700 		1,250 -6.8% 191.76 US$239,700
2025-11-28 2025-11-25 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
4,747 -3.8%
192.97
US$916,037 		4,747 -3.8% 192.97 US$916,037
2025-11-28 2025-11-25 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
41,004 -24.7%
192.27
US$7,883,901 		41,004 -24.7% 192.27 US$7,883,901
2025-11-28 2025-11-25 PlS Planned sale
Davis J. E.

CEO and President

Executive Director
9,342 -5.3%
191.59
US$1,789,823 		9,342 -5.3% 191.59 US$1,789,823
2025-11-25 2025-11-25 PrS Proposed sale
Davis J. E.

Officer; Director

Executive Director
55,093
192.22
US$10,589,762 		55,093 192.22 US$10,589,762
2025-11-25 2025-11-25 PrS Proposed sale
2.6
Gregg Vicky B

Director

Non-Executive Director
1,250
191.76
US$239,700 		1,250 191.76 US$239,700
2025-11-20 2025-11-18 PlS Planned sale
3.3
DELANEY MARK E

SVP & Chief Commercial Officer

Officer
7,946 -51.3%
187.35
US$1,488,683 		7,946 -51.3% 187.35 US$1,488,683
2025-11-18 2025-11-18 PrS Proposed sale
3.3
DELANEY MARK E

Officer

Officer
7,946
187.35
US$1,488,683 		7,946 187.35 US$1,488,683
2025-10-24 2025-10-22 S Sale
0.9
PFEIFFER GARY M
Non-Executive Director
1,482 -4.8%
182.40
US$270,317 		1,482 -4.8% 182.40 US$270,317
2025-10-22 2025-10-22 PrS Proposed sale
0.9
PFEIFFER GARY M

Director

Non-Executive Director
1,482
182.40
US$270,317 		1,482 182.40 US$270,317
2025-09-30 2025-09-26 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
144 -0.4%
188.66
US$27,167 		144 -0.4% 188.66 US$27,167
2025-09-30 2025-09-26 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
83 -0.2%
187.22
US$15,539 		83 -0.2% 187.22 US$15,539
2025-09-26 2025-09-26 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
227
188.13
US$42,706 		227 188.13 US$42,706
2025-09-25 2025-09-24 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
175 -0.5%
187.02
US$32,729 		175 -0.5% 187.02 US$32,729
2025-09-24 2025-09-24 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
175
187.02
US$32,729 		175 187.02 US$32,729
2025-09-25 2025-09-23 PlS Planned sale
2.7
PREVOZNIK MICHAEL E

SVP & General Counsel

Officer
28,288 -42.6%
187.12
US$5,293,313 		28,288 -42.6% 187.12 US$5,293,313
2025-09-23 2025-09-23 PrS Proposed sale
2.7
PREVOZNIK MICHAEL E

Officer

Officer
28,288
187.12
US$5,293,313 		28,288 187.12 US$5,293,313
2025-08-25 2025-08-21 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
1,975 -11.5%
185.00
US$365,375 		1,975 -11.5% 185.00 US$365,375
2025-08-21 2025-08-21 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
1,975
185.00
US$365,375 		1,975 185.00 US$365,375
2025-08-21 2025-08-19 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
4,532 -20.8%
183.00
US$829,356 		4,532 -20.8% 183.00 US$829,356
2025-08-19 2025-08-19 PrS Proposed sale
1.5
Plewman Patrick

Director

Non-Executive Director
4,532
183.00
US$829,356 		4,532 183.00 US$829,356
2025-08-19 2025-08-15 PlS Planned sale
1.5
Plewman Patrick

SVP for Diagnostic Services

Officer
1,975 -10.3%
180.00
US$355,500 		1,975 -10.3% 180.00 US$355,500
2025-08-15 2025-08-15 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
72
180.00
US$12,960 		72 180.00 US$12,960
2025-08-15 2025-08-15 PrS Proposed sale
1.5
Plewman Patrick

Officer

Officer
1,903
180.00
US$342,540 		1,903 180.00 US$342,540

See older Quest Diagnostics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Quest Diagnostics Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Quest Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500